Skip to main content
Caplight Logo









Emobot

Emobot

Private
ParisHealthcare & Life Scienceshttps://emobothealth.com/

Last Round

Accelerator

Apr 16, 2025

Total Funding Raised

$200,000

Company Overview

Emobot is a health technology company that provides a passive, multimodal AI monitoring platform for clinics to detect non-response and relapse in patients with mood disorders.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Vertical SaaS, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

mental health monitoringpassive monitoringAI mental healthdigital biomarkerremote patient monitoringRPMinterventional psychiatrytreatment-resistant depressionpsychiatry softwareon-device AIdigital therapeuticsDTxaffective computingemotional AIclinician dashboardusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emobot Comparables

Compare Emobot with similar companies based on industry and business-model similarity.

Emobot comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kintsugi
78%
Ellipsis Health
76%
Deliberate AI
75%

Emobot Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 16, 2025
GrantOct 1, 2022
GrantFeb 3, 2022

Key People

Founding team and executive leadership

Antony Perzo

CTO & Co-founder

Founding Team

Tanel Petelot

CEO & Co-founder

Founding Team

Samuel Lerman

CPO

Executive Team

Emobot Investors

Notable investors and investment history

Emobot investors
InvestorRounds
iPEPS-ICMAccelerator
OVHcloud Startup ProgramAccelerator
BpifranceGrant, Accelerator
21st by CentraleSupélecAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 2240% MoM, reaching 19.6K.

  • Aug 22, 2025

    Grew 20% QoQ from 15 to 18 employees.

Emobot Filings

Explore SEC and related filing metadata, where available.

Emobot filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Emobot's valuation, stock price, and market status.

Is Emobot a public or private company?

Emobot is a private company.

What is the current stock price of Emobot?

Emobot is a private company with no public stock price. No recent secondary market data is available.

How much is Emobot worth (valuation)?

Valuation information for Emobot is not publicly available.

Can I buy Emobot stock?

Emobot shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Emobot's last funding round?

Funding round information for Emobot is not publicly available.

Who are the main investors in Emobot?

Investor information for Emobot is not publicly disclosed.

Will Emobot IPO soon?

No public IPO plans have been announced for Emobot.

How can I track Emobot secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Emobot's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range15
Year Founded2022
Last FundingApr 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?